Amedeo Smart

Free Medical Literature Service

 

Amedeo

Ischemic Heart Disease
  Free Subscription

Articles published in
BMJ
    September 2026
  1. LIANG J, Choi Y, Shen P, Wells S, et al
    Simultaneous derivation, validation, and comparison of predictor hazard ratios for cardiovascular risk prediction equations in patients with diabetes from high versus non-high income countries: cohort study.
    BMJ. 2026;394:e100535.
    >> Share

    August 2026
  2. KRUGER N, Schneeweiss S, Wang SV
    Tirzepatide and the risk of atherosclerotic cardiovascular events: population based cohort study.
    BMJ. 2026;394:e100011.
    >> Share

  3. DANI SS, Jayakumar A, Ganatra S
    Tirzepatide and cardiovascular outcomes.
    BMJ. 2026;394:e100366.
    >> Share

    July 2026

  4. No-touch versus conventional vein in coronary artery bypass grafting: three year follow-up of multicentre randomised PATENCY trial.
    BMJ. 2026;394:e100400.
    >> Share

  5. TORJESEN I
    Most obesity drugs do not improve quality of life or reduce cardiovascular risk, analysis finds.
    BMJ. 2026;394:e100232.
    >> Share

    May 2026
  6. RAJA SG
    Optimising antiplatelet therapy after coronary artery bypass grafting.
    BMJ. 2026;393:s815.
    >> Share

  7. YUAN X, Li J, Lei L, Zhang L, et al
    Efficacy of dual antiplatelet therapy for three months versus 12 months after coronary artery bypass grafting: multicentre, double blinded, randomised controlled trial.
    BMJ. 2026;393:e088939.
    >> Share

    March 2026

  8. RETRACTION: Prevention of acute myocardial infarction induced heart failure by intracoronary infusion of mesenchymal stem cells: phase 3 randomised clinical trial (PREVENT-TAHA8).
    BMJ. 2026;392:s579.
    >> Share


  9. CORRECTION: Prevention of acute myocardial infarction induced heart failure by intracoronary infusion of mesenchymal stem cells: phase 3 randomised clinical trial (PREVENT-TAHA8).
    BMJ. 2026;392:s574.
    >> Share

  10. TULLY PJ, Gallagher C, Way KL, Anonymous, et al
    Suicide prevention in patients with cardiovascular conditions.
    BMJ. 2026;392:s447.
    >> Share

    January 2026
  11. DIERCKS D, Cao M, McHugh M, Kibbey C, et al
    Evaluation and management of chest pain from cardiovascular causes in female patients.
    BMJ. 2026;392:e086177.
    >> Share


  12. CORRECTION: Exposure to sugar rationing in first 1000 days after conception and long term cardiovascular outcomes: natural experiment study.
    BMJ. 2026;392:s119.
    >> Share

    December 2025

  13. Correction: Ionising radiation and cardiovascular disease: systematic review and meta-analysis.
    BMJ. 2025;391:r2557.
    >> Share


  14. Redressing inequities in women's cardiovascular health.
    BMJ. 2025;391:r2617.
    >> Share

    November 2025
  15. TRUONG T, Ahmed M, Gamayata K, Arachi T, et al
    Redressing inequities in women's cardiovascular health.
    BMJ. 2025;391:r2365.
    >> Share


  16. EXPRESSION OF CONCERN: Prevention of acute myocardial infarction induced heart failure by intracoronary infusion of mesenchymal stem cells: phase 3 randomised clinical trial.
    BMJ. 2025;391:r2388.
    >> Share

    October 2025
  17. ATTAR A, Mirhosseini SA, Mathur A, Dowlut S, et al
    Prevention of acute myocardial infarction induced heart failure by intracoronary infusion of mesenchymal stem cells: phase 3 randomised clinical trial (PREVENT-TAHA8).
    BMJ. 2025;391:e083382.
    >> Share

  18. ZHENG J, Zhou Z, Huang J, Tu Q, et al
    Exposure to sugar rationing in first 1000 days after conception and long term cardiovascular outcomes: natural experiment study.
    BMJ. 2025;391:e083890.
    >> Share

    September 2025
  19. ZHANG J, Liu X, Xu Y
    Cardiovascular toxicity risks in treating EGFR-mutated lung cancer.
    BMJ. 2025;390:r1834.
    >> Share

  20. MA Z, Cao F, Liao M, Min R, et al
    Cardiovascular adverse events associated with epidermal growth factor receptor tyrosine kinase inhibitors in EGFR-mutated non-small cell lung cancer: systematic review and network meta-analysis.
    BMJ. 2025;390:e082834.
    >> Share

  21. BOWIE K
    Clopidogrel better than aspirin for preventing heart attack and stroke in patients with coronary artery disease, study finds.
    BMJ. 2025;390:r1844.
    >> Share

    August 2025
  22. AGARWAL A, Mustafa R, Manja V, Agoritsas T, et al
    Cardiovascular, kidney related, and weight loss effects of therapeutics for type 2 diabetes: a living clinical practice guideline.
    BMJ. 2025;390:e082071.
    >> Share

    July 2025
  23. PICCOLO R, Laino A, Vitale AP, Franzone A, et al
    Sex related differences in efficacy and safety of antithrombotic therapy in patients with coronary artery disease: systematic review and meta-analysis.
    BMJ. 2025;390:e082974.
    >> Share

  24. TAYAL U
    Sex differences in antithrombotic therapy for coronary artery disease.
    BMJ. 2025;390:r1560.
    >> Share

    June 2025
  25. GIACOPPO D, Gragnano F, Watanabe H, Kimura T, et al
    P2Y(12) inhibitor or aspirin after percutaneous coronary intervention: individual patient data meta-analysis of randomised clinical trials.
    BMJ. 2025;389:e082561.
    >> Share

  26. REDDY RK, Bansal R, Ardissino M
    Antiplatelet monotherapy after percutaneous coronary intervention.
    BMJ. 2025;389:r1089.
    >> Share

    May 2025
  27. ZHANG X, Wang S, Zhou X, Tang Y, et al
    A village doctor-led mobile health intervention for cardiovascular risk reduction in rural China: cluster randomised controlled trial.
    BMJ. 2025;389:e082765.
    >> Share

  28. JANSEN C, van der Palen J, Tabak M
    Using mobile health to reduce cardiovascular disease risk.
    BMJ. 2025;389:r972.
    >> Share

  29. BORLAND S
    Why are UK cardiovascular deaths in under 65s rising again?
    BMJ. 2025;389:r1015.
    >> Share


  30. Effects of Medicaid coverage on cardiovascular health outcomes.
    BMJ. 2025;389:r863.
    >> Share


  31. Heterogeneous effects of Medicaid coverage on cardiovascular risk factors: secondary analysis of randomized controlled trial.
    BMJ. 2025;389:r859.
    >> Share

    April 2025
  32. JIANG H
    No-touch vein harvesting in coronary artery bypass surgery.
    BMJ. 2025;389:r728.
    >> Share

  33. TIAN M, Wang X, Feng W, Wang H, et al
    No-touch versus conventional vein in coronary artery bypass grafting: three year follow-up of multicentre randomised PATENCY trial.
    BMJ. 2025;389:e082883.
    >> Share

    March 2025
  34. GAO C, Zhu B, Ouyang F, Wen S, et al
    Stepwise dual antiplatelet therapy de-escalation in patients after drug coated balloon angioplasty (REC-CAGEFREE II): multicentre, randomised, open label, assessor blind, non-inferiority trial.
    BMJ. 2025;388:e082945.
    >> Share

  35. BELLOLIO F, Gottlieb M, Body R, Than MP, et al
    Evaluating patients with chest pain in the emergency department.
    BMJ. 2025;388:r136.
    >> Share

  36. HAN J, Zhai W, Wu Z, Zhang Z, et al
    Care guided by tissue oxygenation and haemodynamic monitoring in off-pump coronary artery bypass grafting (Bottomline-CS): assessor blind, single centre, randomised controlled trial.
    BMJ. 2025;388:e082104.
    >> Share

    February 2025
  37. YONIS H, Lokkegaard E, Kragholm K, Granger CB, et al
    Stroke and myocardial infarction with contemporary hormonal contraception: real-world, nationwide, prospective cohort study.
    BMJ. 2025;388:e082801.
    >> Share

  38. WISE J
    Exercise referral rates for patients with risk of cardiovascular disease vary widely across England, study reports.
    BMJ. 2025;388:r287.
    >> Share

    January 2025
  39. HU W, Tao C, Wang L, Chen Z, et al
    Intra-arterial tenecteplase after successful endovascular recanalisation in patients with acute posterior circulation arterial occlusion (ATTENTION-IA): multicentre randomised controlled trial.
    BMJ. 2025;388:e080489.
    >> Share

    November 2024
  40. JOHANSSON T, Karlsson T, Bliuc D, Schmitz D, et al
    Contemporary menopausal hormone therapy and risk of cardiovascular disease: Swedish nationwide register based emulated target trial.
    BMJ. 2024;387:e078784.
    >> Share

  41. MAHASE E
    Cardiovascular disease: Just one in 12 eligible people had health check last year, watchdog finds.
    BMJ. 2024;387:q2518.
    >> Share

    October 2024

  42. Trends in cardiovascular disease incidence among 22 million people in the UK over 20 years: population based study.
    BMJ. 2024;387:q2381.
    >> Share

  43. LU J, Xu Y, Bi Y, Wang T, et al
    Reducing inequity through tackling social determinants of cardiovascular diseases in China.
    BMJ. 2024;387:e079197.
    >> Share

    September 2024
  44. INOUE K, Athey S, Baicker K, Tsugawa Y, et al
    Heterogeneous effects of Medicaid coverage on cardiovascular risk factors: secondary analysis of randomized controlled trial.
    BMJ. 2024;386:e079377.
    >> Share

  45. YANG C, Tebbutt SJ
    Effects of Medicaid coverage on cardiovascular health outcomes.
    BMJ. 2024;386:q1807.
    >> Share

    August 2024
  46. MENG R, Wang W, Huang T, Zhan S, et al
    Tackling social and behavioural risk factors for cardiovascular diseases in Chinese women.
    BMJ. 2024;386:e078638.
    >> Share

  47. MAHASE E
    Incidence of cardiovascular events was lower after covid-19 vaccination, study finds.
    BMJ. 2024;386:q1732.
    >> Share

    July 2024
  48. IACOBUCCI G
    Semaglutide: UK regulator approves drug for prevention of cardiovascular events.
    BMJ. 2024;386:q1660.
    >> Share

    June 2024

  49. Re-evaluation of the traditional diet-heart hypothesis: analysis of recovered data from Minnesota Coronary Experiment (1968-73).
    BMJ. 2024;385:q1450.
    >> Share

  50. CONRAD N, Molenberghs G, Verbeke G, Zaccardi F, et al
    Trends in cardiovascular disease incidence among 22 million people in the UK over 20 years: population based study.
    BMJ. 2024;385:e078523.
    >> Share

  51. ZHU Y, Zhang W, Dimagli A, Han L, et al
    Antiplatelet therapy after coronary artery bypass surgery: five year follow-up of randomised DACAB trial.
    BMJ. 2024;385:e075707.
    >> Share

  52. SANDNER S
    Dual antiplatelet therapy after coronary artery bypass surgery.
    BMJ. 2024;385:q1083.
    >> Share


  53. Effect of combination treatment with glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter-2 inhibitors on incidence of cardiovascular and serious renal events: population based cohort study.
    BMJ. 2024;385:q1237.
    >> Share

    May 2024
  54. DYER C
    Former cardiovascular surgery lead is charged with 14 counts of sexual assault.
    BMJ. 2024;385:q1188.
    >> Share


  55. Cardiovascular toxicity of immune therapies for cancer.
    BMJ. 2024;385:q1197.
    >> Share


  56. Effect of combination treatment with glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter-2 inhibitors on incidence of cardiovascular and serious renal events: population based cohort study.
    BMJ. 2024;385:q1094.
    >> Share

  57. PALASKAS NL, Ali HJ, Koutroumpakis E, Ganatra S, et al
    Cardiovascular toxicity of immune therapies for cancer.
    BMJ. 2024;385:e075859.
    >> Share

  58. LI Z, Min XW, He PG, Zhang CH, et al
    Chest pain with diffuse ST segment elevation.
    BMJ. 2024;385:e078403.
    >> Share

    April 2024
  59. SIMMS-WILLIAMS N, Treves N, Yin H, Lu S, et al
    Effect of combination treatment with glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter-2 inhibitors on incidence of cardiovascular and serious renal events: population based cohort study.
    BMJ. 2024;385:e078242.
    >> Share

  60. MOK PLH, Carr MJ, Guthrie B, Morales DR, et al
    Multiple adverse outcomes associated with antipsychotic use in people with dementia: population based matched cohort study.
    BMJ. 2024;385:e076268.
    >> Share

  61. VINTER N, Cordsen P, Johnsen SP, Staerk L, et al
    Temporal trends in lifetime risks of atrial fibrillation and its complications between 2000 and 2022: Danish, nationwide, population based cohort study.
    BMJ. 2024;385:e077209.
    >> Share

    March 2024
  62. WONDERLING D, Mariani A, Samarasekera EJ, Wilkinson C, et al
    Secondary prevention of cardiovascular disease, including cholesterol targets: summary of updated NICE guidance.
    BMJ. 2024;384:q637.
    >> Share

  63. SAUL H, Deeney B, Swaithes L, Hounkpatin H, et al
    Even short periods of diabetes remission are linked to lower risk of heart attack and stroke.
    BMJ. 2024;384:q516.
    >> Share

  64. TANNE JH
    Wegovy: FDA approves weight loss drug to cut cardiovascular risk.
    BMJ. 2024;384:q642.
    >> Share

    February 2024

  65. Exposure-response associations between chronic exposure to fine particulate matter and risks of hospital admission for major cardiovascular diseases: population based cohort study.
    BMJ. 2024;384:q517.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016